<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title> &#187; Medical Research</title>
	<atom:link href="http://pharmaexecnews.com/category/pharmaceuticals/medical-research/feed/" rel="self" type="application/rss+xml" />
	<link>http://pharmaexecnews.com</link>
	<description></description>
	<lastBuildDate>Fri, 29 Apr 2011 14:00:12 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.4</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>New Plan of Attack Against Breast Cancer Stem Cells</title>
		<link>http://pharmaexecnews.com/biotechnology/plan-attack-breast-cancer-stem-cells/</link>
		<comments>http://pharmaexecnews.com/biotechnology/plan-attack-breast-cancer-stem-cells/#comments</comments>
		<pubDate>Fri, 21 Jan 2011 08:00:29 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Markets]]></category>
		<category><![CDATA[Medical Research]]></category>
		<category><![CDATA[Research Reports]]></category>
		<category><![CDATA[Women's Health]]></category>
		<category><![CDATA[biotech industry]]></category>
		<category><![CDATA[biotechnology industry]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[Breast cancer]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[embryonic stem cell research]]></category>
		<category><![CDATA[understanding stem cell research]]></category>
		<category><![CDATA[Understanding the Global Biotech Industry]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11094</guid>
		<description><![CDATA[It was Max Wicha of the University of Michigan who first identified breast cancer stem cells back in 2003. Now, Wicha and colleagues have identified a possible way to attack these cells, which are responsible for a tumor&#8217;s growth and spread.

The researchers found that breast cancer stem cells are regulated by a type of cell [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/plan-attack-breast-cancer-stem-cells/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Alzheimer&#8217;s: Therapy for Brain Disease Could Target Blood</title>
		<link>http://pharmaexecnews.com/biotechnology/alzheimers-therapy-brain-disease-target-blood/</link>
		<comments>http://pharmaexecnews.com/biotechnology/alzheimers-therapy-brain-disease-target-blood/#comments</comments>
		<pubDate>Wed, 05 Jan 2011 08:00:19 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Bioinformatics]]></category>
		<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Disease]]></category>
		<category><![CDATA[Markets]]></category>
		<category><![CDATA[Medical Research]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[biotech industry]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[pharmaceutical industry]]></category>
		<category><![CDATA[Strategic Alliances in World Pharma and Biotech Markets]]></category>
		<category><![CDATA[Understanding the Global Biotech Industry]]></category>
		<category><![CDATA[Understanding the Global Pharmaceutical Market]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11043</guid>
		<description><![CDATA[The aggregated proteins strewn about the brain are the hallmark of one of the most common neurodegenerative disorders: Alzheimer&#8217;s disease. But while these irregular, gunky proteins, called amyloid-β, are believed to contribute to the deterioration of memory and cognitive ability in Alzheimer&#8217;s patients, no one knows how they lead to these symptoms, and the severity [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/alzheimers-therapy-brain-disease-target-blood/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Gold-plated Liposomes an Anti-Cancer Stocking Stuffer</title>
		<link>http://pharmaexecnews.com/biotechnology/goldplated-liposomes-anticancer-stocking-stuffer/</link>
		<comments>http://pharmaexecnews.com/biotechnology/goldplated-liposomes-anticancer-stocking-stuffer/#comments</comments>
		<pubDate>Thu, 30 Dec 2010 08:00:17 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Drug Delivery]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Industry News]]></category>
		<category><![CDATA[Markets]]></category>
		<category><![CDATA[Medical Patents]]></category>
		<category><![CDATA[Medical Research]]></category>
		<category><![CDATA[R&D]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[biotechnology industry]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[c reactive protein]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[cancer therapies]]></category>
		<category><![CDATA[nanobiotechnology]]></category>
		<category><![CDATA[nanotechnology]]></category>
		<category><![CDATA[Nanotechnology - Revolutionizing R&D to Develop Smarter Therapeutics and Diagnostics]]></category>
		<category><![CDATA[pharmaceutical industry]]></category>
		<category><![CDATA[Understanding the Global Biotech Industry]]></category>
		<category><![CDATA[Understanding the Global Pharmaceutical Market]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11018</guid>
		<description><![CDATA[No, gold-plated liposomes are not a luxury gift that you&#8217;d find in your Christmas stocking, but they could someday give cancer patients the gift of life by selectively knocking out cancer cells while leaving healthy ones alone. This holiday gift comes courtesy of Marek Romanowski, an associate professor of biomedical engineering in the University of [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/goldplated-liposomes-anticancer-stocking-stuffer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Alzheimer&#8217;s: Tau Disrupts Neural Communication Prior to Neurodegeneration</title>
		<link>http://pharmaexecnews.com/biotechnology/alzheimers-tau-disrupts-neural-communication-prior-neurodegeneration/</link>
		<comments>http://pharmaexecnews.com/biotechnology/alzheimers-tau-disrupts-neural-communication-prior-neurodegeneration/#comments</comments>
		<pubDate>Wed, 29 Dec 2010 08:00:42 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Bioinformatics]]></category>
		<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Central Nervous System]]></category>
		<category><![CDATA[Disease]]></category>
		<category><![CDATA[Markets]]></category>
		<category><![CDATA[Medical Research]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[biotech news]]></category>
		<category><![CDATA[biotechnology industry]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[molecular biology]]></category>
		<category><![CDATA[pharmaceutical industry]]></category>
		<category><![CDATA[Understanding the Global Biotech Industry]]></category>
		<category><![CDATA[Understanding the Global Pharmaceutical Market]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11027</guid>
		<description><![CDATA[A new study is unraveling the earliest events associated with neurodegenerative diseases characterized by abnormal accumulation of tau protein. The research reveals how tau disrupts neuronal communication at synapses and may help to guide development of therapeutic strategies that precede irreversible neuronal degeneration.

Tau normally contributes to the supportive framework of proteins in the cell. It [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/alzheimers-tau-disrupts-neural-communication-prior-neurodegeneration/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>New Parkinson’s Drug Development</title>
		<link>http://pharmaexecnews.com/biotechnology/parkinsons-drug-development/</link>
		<comments>http://pharmaexecnews.com/biotechnology/parkinsons-drug-development/#comments</comments>
		<pubDate>Tue, 02 Nov 2010 08:00:21 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Bioinformatics]]></category>
		<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Disease]]></category>
		<category><![CDATA[Drug Discovery]]></category>
		<category><![CDATA[Industry News Alerts]]></category>
		<category><![CDATA[Markets]]></category>
		<category><![CDATA[Medical Patents]]></category>
		<category><![CDATA[Medical Research]]></category>
		<category><![CDATA[New Drugs]]></category>
		<category><![CDATA[R&D]]></category>
		<category><![CDATA[Research Reports]]></category>
		<category><![CDATA[bioengineering]]></category>
		<category><![CDATA[biotech industry]]></category>
		<category><![CDATA[biotechnology industry]]></category>
		<category><![CDATA[Gene therapy]]></category>
		<category><![CDATA[pharmaceutical industry]]></category>
		<category><![CDATA[Strategic Alliances in World Pharma and Biotech Markets]]></category>
		<category><![CDATA[Understanding the Global Biotech Industry]]></category>
		<category><![CDATA[Understanding the Global Pharmaceutical Market]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=10846</guid>
		<description><![CDATA[The side effects of the standard medication for Parkinson&#8217;s disease have long been a preoccupation of brain researchers. Now Daniella Rylander has presented new findings in a recently defended PhD thesis at Lund University that provide hope of more effective medication for those who suffer from the nerve cell disease.

In her thesis, neuroscience researcher Daniella [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/parkinsons-drug-development/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Diagnosing Autism with MRI</title>
		<link>http://pharmaexecnews.com/biotechnology/diagnosing-autism-mri/</link>
		<comments>http://pharmaexecnews.com/biotechnology/diagnosing-autism-mri/#comments</comments>
		<pubDate>Mon, 25 Oct 2010 08:00:02 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Bioinformatics]]></category>
		<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Devices and Technology]]></category>
		<category><![CDATA[Disease]]></category>
		<category><![CDATA[Industry News]]></category>
		<category><![CDATA[Industry News Alerts]]></category>
		<category><![CDATA[Markets]]></category>
		<category><![CDATA[Medical]]></category>
		<category><![CDATA[Medical Research]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[biotech news]]></category>
		<category><![CDATA[biotechnology industry]]></category>
		<category><![CDATA[Understanding the Global Biotech Industry]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=10822</guid>
		<description><![CDATA[University of Utah (U of U) medical researchers have made an important step in diagnosing autism through using MRI, an advance that eventually could help health care providers indentify the problem much earlier in children and lead to improved treatment and outcomes for those with the disorder.

In a study published on October 15, 2010 in [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/diagnosing-autism-mri/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Sanofi Target Genzyme More Attractive to Buyers With Unit Sales</title>
		<link>http://pharmaexecnews.com/biotechnology/biomedical/sanofi-target-genzyme-attractive-buyers-unit-sales/</link>
		<comments>http://pharmaexecnews.com/biotechnology/biomedical/sanofi-target-genzyme-attractive-buyers-unit-sales/#comments</comments>
		<pubDate>Wed, 29 Sep 2010 08:00:24 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Companies]]></category>
		<category><![CDATA[Deals and Mergers]]></category>
		<category><![CDATA[Devices and Technology]]></category>
		<category><![CDATA[Disease]]></category>
		<category><![CDATA[Financial]]></category>
		<category><![CDATA[Industry News]]></category>
		<category><![CDATA[Market News]]></category>
		<category><![CDATA[Markets]]></category>
		<category><![CDATA[Medical Patents]]></category>
		<category><![CDATA[Medical Research]]></category>
		<category><![CDATA[New Drugs]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[R&D]]></category>
		<category><![CDATA[biotech news]]></category>
		<category><![CDATA[biotechnology industry]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[genetics]]></category>
		<category><![CDATA[Genomics]]></category>
		<category><![CDATA[pharmaceutical companies]]></category>
		<category><![CDATA[pharmaceutical industry]]></category>
		<category><![CDATA[Understanding the Global Biotech Industry]]></category>
		<category><![CDATA[Understanding the Global Pharmaceutical Market]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=10746</guid>
		<description><![CDATA[Genzyme Corp., a takeover target of Sanofi-Aventis SA, expects to complete sales of its diagnostics and pharmaceutical-ingredients units by the end of the year.  Genzyme has six bidders for the drug business, Chief Financial Officer Michael Wyzga said today at an investor conference. Sale of the units will make Genzyme more appealing to potential buyers, [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/biomedical/sanofi-target-genzyme-attractive-buyers-unit-sales/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Four Drugs Look to Pass FDA Muster this Month</title>
		<link>http://pharmaexecnews.com/biotechnology/drugs-pass-fda-muster-month/</link>
		<comments>http://pharmaexecnews.com/biotechnology/drugs-pass-fda-muster-month/#comments</comments>
		<pubDate>Fri, 17 Sep 2010 08:00:01 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Companies]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[Financial]]></category>
		<category><![CDATA[General News]]></category>
		<category><![CDATA[Industry News]]></category>
		<category><![CDATA[Industry News Alerts]]></category>
		<category><![CDATA[Market News]]></category>
		<category><![CDATA[Markets]]></category>
		<category><![CDATA[Medical Patents]]></category>
		<category><![CDATA[Medical Research]]></category>
		<category><![CDATA[New Drugs]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[R&D]]></category>
		<category><![CDATA[Regulatory]]></category>
		<category><![CDATA[Research Reports]]></category>
		<category><![CDATA[Virus]]></category>
		<category><![CDATA[biotech]]></category>
		<category><![CDATA[biotech industry]]></category>
		<category><![CDATA[biotech news]]></category>
		<category><![CDATA[biotechnology industry]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[pharmaceutical industry]]></category>
		<category><![CDATA[Understanding the Global Biotech Industry]]></category>
		<category><![CDATA[Understanding the Global Pharmaceutical Market]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=10711</guid>
		<description><![CDATA[Brian Orelli of The Motley Fool highlights four drugs&#8211;AstraZeneca&#8217;s Brilinta, Questcor&#8217;s Acthar Gel, Savient&#8217;s Krystexxa and Novartis&#8217; Gilenia&#8211;that could gain FDA approval this month despite some previous difficulties. However, given recent troubles with other approved drugs, the FDA&#8217;s cautious nature could cause issues for some of the drugmakers.

Back in July, Brilinta received a 7-to-1 FDA [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/drugs-pass-fda-muster-month/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Cockroach Brains May Be a Source of Antibiotics</title>
		<link>http://pharmaexecnews.com/biotechnology/cockroach-brains-source-antibiotics/</link>
		<comments>http://pharmaexecnews.com/biotechnology/cockroach-brains-source-antibiotics/#comments</comments>
		<pubDate>Thu, 16 Sep 2010 08:00:07 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Bioinformatics]]></category>
		<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Disease]]></category>
		<category><![CDATA[Drug Discovery]]></category>
		<category><![CDATA[Financial]]></category>
		<category><![CDATA[General News]]></category>
		<category><![CDATA[Industry News]]></category>
		<category><![CDATA[Industry News Alerts]]></category>
		<category><![CDATA[Infectious Diseases]]></category>
		<category><![CDATA[Market News]]></category>
		<category><![CDATA[Markets]]></category>
		<category><![CDATA[Medical Research]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[R&D]]></category>
		<category><![CDATA[bioengineering]]></category>
		<category><![CDATA[biomolecules]]></category>
		<category><![CDATA[biotech]]></category>
		<category><![CDATA[biotech industry]]></category>
		<category><![CDATA[biotech news]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[molecular biology]]></category>
		<category><![CDATA[pharmaceutical industry]]></category>
		<category><![CDATA[Understanding the Global Biotech Industry]]></category>
		<category><![CDATA[Understanding the Global Pharmaceutical Market]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=10707</guid>
		<description><![CDATA[Cockroach brains may be a source of new antibiotics capable of killing deadly drug-resistant bacteria, according to research that suggests the germ-spreading pests may be good for something after all. Insects such as cockroaches have a defense mechanism against bacteria, a “logical” development from living in unhygienic conditions, research from the U.K.’s University of Nottingham [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/cockroach-brains-source-antibiotics/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Research Scientists Brace for Layoffs as Stimulus Cash Dries Up</title>
		<link>http://pharmaexecnews.com/biotechnology/research-scientists-brace-layoffs-stimulus-cash-dries/</link>
		<comments>http://pharmaexecnews.com/biotechnology/research-scientists-brace-layoffs-stimulus-cash-dries/#comments</comments>
		<pubDate>Fri, 10 Sep 2010 08:00:34 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Bioinformatics]]></category>
		<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Drug Discovery]]></category>
		<category><![CDATA[Financial]]></category>
		<category><![CDATA[Government Policy]]></category>
		<category><![CDATA[Industry News]]></category>
		<category><![CDATA[Industry News Alerts]]></category>
		<category><![CDATA[Market News]]></category>
		<category><![CDATA[Markets]]></category>
		<category><![CDATA[Medical Research]]></category>
		<category><![CDATA[R&D]]></category>
		<category><![CDATA[Research Reports]]></category>
		<category><![CDATA[bioengineering]]></category>
		<category><![CDATA[Bioinformatics Market Potential]]></category>
		<category><![CDATA[biotech]]></category>
		<category><![CDATA[biotech industry]]></category>
		<category><![CDATA[biotech news]]></category>
		<category><![CDATA[biotechnology industry]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[pharmaceutical industry]]></category>
		<category><![CDATA[Understanding the Global Biotech Industry]]></category>
		<category><![CDATA[Understanding the Global Pharmaceutical Market]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=10691</guid>
		<description><![CDATA[The stimulus bill that pumped more than $8 billion into biomedical research projects in the U.S. is set to end at the end of the month. And the surge of research work that it helped spawn is likely to come to a quick stop, triggering stinging job losses as research scientists jockey for a piece [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/research-scientists-brace-layoffs-stimulus-cash-dries/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

